Regenerative Medicine News

Pluristem Develops Point-of-Care Thawing Device for PLX Cells
NASDAQ
As part of the company's comprehensive approach in developing high quality, easy to use PLX cell therapy candidate products, the device ensures the uniform thawing of PLX cells across all doses. Pluristem's "off-the-shelf" PLX cell therapy product ...
See all stories on this topic »​